<SEC-DOCUMENT>0001209191-17-051325-index.html : 20170905
<SEC-HEADER>0001209191-17-051325.hdr.sgml : 20170905
<ACCEPTANCE-DATETIME>20170905163608
ACCESSION NUMBER:		0001209191-17-051325
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170831
FILED AS OF DATE:		20170905
DATE AS OF CHANGE:		20170905

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MacLean Michael F
		CENTRAL INDEX KEY:			0001383731

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38137
		FILM NUMBER:		171069134

	MAIL ADDRESS:	
		STREET 1:		14 CAMBRIDGE CENTER
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AKCEA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001662524
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472608175
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		55 CAMBRIDGE PARKWAY
		STREET 2:		SUITE 100
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		760-603-2732

	MAIL ADDRESS:	
		STREET 1:		2855 GAZELLE CT
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92010
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>